Bergman, Joakim
Burman, Joachim
Bergenheim, Tommy
Svenningsson, Anders http://orcid.org/0000-0003-0663-2220
Funding for this research was provided by:
National Multiple Sclerosis Society (PA 0185)
Research Fund for Clinical Neuroscience at Umeå University Hospital
Regional Agreement Between Umeå University and Västerbotten County Council on Cooperation in the Field of Medicine, Odontology and Health
Article History
Received: 1 June 2020
Revised: 31 August 2020
Accepted: 2 September 2020
First Online: 8 September 2020
Compliance with ethical standards
:
: Joakim Bergman reports no disclosures. Joachim Burman reports no disclosures. Tommy Bergenheim reports no disclosures. Anders Svenningsson reports no disclosures.
: The original ITT-PMS study and the extension study were both approved by the Regional Ethical Review Board in Umeå and registered with the EU Clinical Trial Register (EudraCT; 2008-002626-11 and 2012-000721-53, respectively). The trials were performed in accordance with standards of GCP and the principles of the Declaration of Helsinki.